A Missouri judge preliminarily approved a $7.25 billion Roundup settlement, with payments over 21 years, as Bayer faces ongoing legal challenges.

A Missouri judge has granted preliminary approval to a $7.25 billion settlement resolving most of the approximately 65,000 remaining lawsuits claiming Bayer’s Roundup weedkiller causes non-Hodgkin’s lymphoma. The agreement, which does not require Bayer to admit fault, would fund payments over 21 years and includes a $500 million deposit for administration. Affected individuals have 90 days to opt out or object before a final decision in July. The settlement comes amid Bayer’s 2025 loss of 3.62 billion euros, driven by legal charges tied to the litigation. The company, which acquired Monsanto in 2018, maintains Roundup is safe despite the International Agency for Research on Cancer classifying glyphosate as a probable carcinogen. A pending Supreme Court case could influence the broader legal landscape.